Bimatoprost for Eyelash Growth in Japanese Subjects: Two Multicenter Controlled Studies
Authors:
Open Access
- 19 March 2014
- journal article
- research article
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 38 (2) , 451-460
Abstract
Bimatoprost 0.03 % has enhanced eyelash prominence in clinical trials enrolling mostly Caucasian subjects. The studies described in this report evaluated the efficacy and safety of bimatoprost in Japanese subjects with idiopathic and chemotherapy-induced eyelash hypotrichosis.Keywords
This publication has 25 references indexed in Scilit:
- The biodisposition and hypertrichotic effects of bimatoprost in mouse skinExperimental Dermatology, 2013
- Eyelash growth in subjects treated with bimatoprost: A multicenter, randomized, double-masked, vehicle-controlled, parallel-group studyJournal of the American Academy of Dermatology, 2012
- Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trialsClinical Ophthalmology, 2011
- Enhanced Eyelashes: Prescription and Over-the-Counter OptionsAesthetic Plastic Surgery, 2010
- Bimatoprost 0.03% gel for cosmetic eyelash growth and enhancementJournal of Cosmetic Dermatology, 2010
- Eyelash Growth from Application of Bimatoprost in Gel Suspension to the Base of the EyelashesOphthalmology, 2010
- The Circadian Curve of Intraocular Pressure: Can We Estimate Its Characteristics during Office Hours?Investigative Ophthalmology & Visual Science, 2009
- Intraocular pressureContinuing Education in Anaesthesia Critical Care & Pain, 2008
- Letter to the Editor: Hypertrichosis of the Eyelashes from Prostaglandin Analog Use: A Blessing or a Bother to the Patient?Journal of Ocular Pharmacology and Therapeutics, 2006
- Chemotherapy-induced alopecia: psychosocial impact and therapeutic approachesSupportive Care in Cancer, 2004